Switching antiretroviral therapy: why, when and how.
Wilkin
Timothy
T
Weill Medical College, Cornell University, New York, USA.
Glesby
Marshall
M
Gulick
Roy M
RM
D050153:Abdominal Fat; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000139:chemically induced; D024882:Drug Resistance, Viral; D050171:Dyslipidemias / Q000139:chemically induced; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000139:chemically induced; D010349:Patient Compliance; D010818:Practice Patterns, Physicians'; D011788:Quality of Life; D019562:Viral Load
D019380:Anti-HIV Agents